PAVmed (PAVM) Competitors $0.72 -0.04 (-5.26%) (As of 12/16/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends PAVM vs. XAIR, STIM, POCI, IRIX, CODX, FEMY, NXGL, ALUR, DRIO, and VVOSShould you be buying PAVmed stock or one of its competitors? The main competitors of PAVmed include Beyond Air (XAIR), Neuronetics (STIM), Precision Optics (POCI), IRIDEX (IRIX), Co-Diagnostics (CODX), Femasys (FEMY), NEXGEL (NXGL), Allurion Technologies (ALUR), DarioHealth (DRIO), and Vivos Therapeutics (VVOS). These companies are all part of the "medical equipment" industry. PAVmed vs. Beyond Air Neuronetics Precision Optics IRIDEX Co-Diagnostics Femasys NEXGEL Allurion Technologies DarioHealth Vivos Therapeutics PAVmed (NASDAQ:PAVM) and Beyond Air (NASDAQ:XAIR) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, valuation, dividends, profitability, institutional ownership, community ranking, media sentiment, earnings and analyst recommendations. Does the media refer more to PAVM or XAIR? In the previous week, PAVmed had 3 more articles in the media than Beyond Air. MarketBeat recorded 4 mentions for PAVmed and 1 mentions for Beyond Air. Beyond Air's average media sentiment score of 0.73 beat PAVmed's score of 0.02 indicating that Beyond Air is being referred to more favorably in the news media. Company Overall Sentiment PAVmed Neutral Beyond Air Positive Is PAVM or XAIR more profitable? PAVmed has a net margin of 602.97% compared to Beyond Air's net margin of -2,369.17%. PAVmed's return on equity of 0.00% beat Beyond Air's return on equity.Company Net Margins Return on Equity Return on Assets PAVmed602.97% N/A -92.36% Beyond Air -2,369.17%-227.29%-106.51% Does the MarketBeat Community favor PAVM or XAIR? PAVmed received 155 more outperform votes than Beyond Air when rated by MarketBeat users. However, 69.57% of users gave Beyond Air an outperform vote while only 66.12% of users gave PAVmed an outperform vote. CompanyUnderperformOutperformPAVmedOutperform Votes20366.12% Underperform Votes10433.88% Beyond AirOutperform Votes4869.57% Underperform Votes2130.43% Which has higher earnings and valuation, PAVM or XAIR? Beyond Air has lower revenue, but higher earnings than PAVmed. Beyond Air is trading at a lower price-to-earnings ratio than PAVmed, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPAVmed$2.45M3.39-$64.18M-$4.35-0.17Beyond Air$1.16M29.73-$60.24M-$1.41-0.34 Do analysts rate PAVM or XAIR? PAVmed presently has a consensus price target of $19.00, indicating a potential upside of 2,433.33%. Beyond Air has a consensus price target of $3.67, indicating a potential upside of 667.41%. Given PAVmed's stronger consensus rating and higher probable upside, research analysts clearly believe PAVmed is more favorable than Beyond Air.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PAVmed 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50Beyond Air 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.00 Do insiders & institutionals believe in PAVM or XAIR? 19.9% of PAVmed shares are owned by institutional investors. Comparatively, 31.5% of Beyond Air shares are owned by institutional investors. 14.7% of PAVmed shares are owned by insiders. Comparatively, 20.1% of Beyond Air shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Which has more volatility and risk, PAVM or XAIR? PAVmed has a beta of 0.67, suggesting that its share price is 33% less volatile than the S&P 500. Comparatively, Beyond Air has a beta of -0.23, suggesting that its share price is 123% less volatile than the S&P 500. SummaryPAVmed beats Beyond Air on 10 of the 18 factors compared between the two stocks. Ad Insiders ExposedHas Trump Finally Gone Too Far?Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover Get PAVmed News Delivered to You Automatically Sign up to receive the latest news and ratings for PAVM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PAVM vs. The Competition Export to ExcelMetricPAVmedSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.30M$4.36B$4.87B$9.24BDividend YieldN/A44.87%7.19%4.01%P/E Ratio-0.1723.05120.5417.21Price / Sales3.3947.321,410.9283.62Price / CashN/A56.8339.9738.31Price / Book-0.227.454.975.11Net Income-$64.18M$13.26M$114.14M$223.18M7 Day Performance-11.99%1.01%130.64%2.70%1 Month Performance-34.21%5.97%139.76%10.11%1 Year Performance-79.84%54.22%161.60%24.65% PAVmed Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PAVMPAVmed4.129 of 5 stars$0.72-5.3%$19.00+2,537.4%-79.4%$7.98M$2.45M-0.1790XAIRBeyond Air4.4255 of 5 stars$0.50+1.4%$3.67+640.7%-70.4%$35.73M$1.16M0.0070STIMNeuronetics3.6 of 5 stars$1.16-9.1%$4.67+304.0%-47.9%$35.05M$71.35M0.00180Short Interest ↓News CoverageGap UpPOCIPrecision Optics0.647 of 5 stars$5.05-0.8%N/A-19.4%$32.07M$19.10M0.0080IRIXIRIDEX0.7985 of 5 stars$1.79flat$2.00+11.7%-35.6%$29.79M$51.87M0.00120CODXCo-Diagnostics4.3546 of 5 stars$0.87+1.7%$1.50+73.4%-27.0%$27.63M$7.32M-0.62100Gap DownFEMYFemasys2.8601 of 5 stars$1.14+2.2%$10.00+773.6%+36.9%$26.21M$1.07M0.0030Short Interest ↑NXGLNEXGEL1.7048 of 5 stars$3.60+3.2%N/A+114.1%$24.44M$4.09M-6.0210Positive NewsALURAllurion Technologies2.483 of 5 stars$0.38+1.6%$2.88+657.8%-90.2%$24.42M$53.47M0.00501Short Interest ↑DRIODarioHealth2.5073 of 5 stars$0.68-11.7%$4.00+488.1%-58.7%$23.19M$20.35M0.00200Positive NewsGap DownHigh Trading VolumeVVOSVivos Therapeutics3.1064 of 5 stars$4.50+7.9%$6.30+40.0%-49.9%$21.78M$13.80M-0.73160Positive NewsGap Up Related Companies and Tools Related Companies Beyond Air Competitors Neuronetics Competitors Precision Optics Competitors IRIDEX Competitors Co-Diagnostics Competitors Femasys Competitors NEXGEL Competitors Allurion Technologies Competitors DarioHealth Competitors Vivos Therapeutics Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PAVM) was last updated on 12/16/2024 by MarketBeat.com Staff From Our PartnersMedia Is Mocking Elon, But Wait Until They See This DemoElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredWall Street Icon: “If you wait on this, it will already be too late”...Investing legend Louis Navellier warned us about the stock market crash of 1987... the 2000 dot-com crash… Enr...InvestorPlace | Sponsored"This looks and feels like 2000," says investing legendOur senior analyst Dan Ferris says a new surprise crisis could begin at any moment... and this time, he says i...Stansberry Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PAVmed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PAVmed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PAVM Stock Alerts